Active ingredients
Pharmacological Group
Used in the treatment
- T30 Burn and corrosion, body region unspecified
- R53 Malaise and fatigue
- L98.4.2* Trophic skin ulcer
- L40 Psoriasis
- K74 Fibrosis and cirrhosis of liver
- K26 Duodenal ulcer
- I99 Other and unspecified disorders of circulatory system
- I87.2 Venous insufficiency (chronic)(peripheral)
- I82 Other venous embolism and thrombosis
- I80 Phlebitis and thrombophlebitis
- I74.9 Embolism and thrombosis of unspecified artery
- I70.9 Generalized and unspecified atherosclerosis
- I50.0 Congestive heart failure
- I25.9 Chronic ischaemic heart disease, unspecified
- H36.0 Diabetic retinopathy (E10-E14+ with common fourth character .3)
- G96.9 Disorder of central nervous system, unspecified
- G35 Multiple sclerosis
- E83.0 Disorders of copper metabolism
- E80.2 Other porphyria
- E63 Other nutritional deficiencies
- B18.9 Chronic viral hepatitis, unspecified
- T56.0 Toxic effect, lead and its compounds
- Z98.8 Other specified postsurgical states
- H35 Other retinal disorders